Literature DB >> 7964746

Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies.

H Martin1, J Rostas, Y Patel, A Aitken.   

Abstract

The 14-3-3 protein family, which is present at particularly high concentrations in mammalian brain, is known to be involved in various cellular functions, including protein kinase C regulation and exocytosis. Despite the fact that most of the 14-3-3 proteins are cytosolic, a small but significant proportion of 14-3-3 in brain is tightly and selectively associated with some membranes. Using a panel of isoform-specific antisera we find that the epsilon, eta, gamma, beta, and zeta isoforms are all present in purified synaptic membranes but absent from mitochondrial and myelin membranes. In addition, the eta, epsilon, and gamma isoforms but not the beta and zeta isoforms are associated with isolated synaptic junctions. When different populations of synaptosomes were fractionated by a nonequilibrium Percoll gradient procedure, the epsilon and gamma isoforms were present and the beta and zeta isoforms were absent from the membranes of synaptosomes sedimenting in the more dense parts of the gradient. The finding that these proteins are associated with different populations of synaptic membranes suggests that they are selectively expressed in different classes of neurones and raises the possibility that some or all of them may influence neurotransmission by regulating exocytosis and/or phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964746     DOI: 10.1046/j.1471-4159.1994.63062259.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  53 in total

1.  Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling.

Authors:  J M Angelastro; L Klimaschewski; S Tang; O V Vitolo; T A Weissman; L T Donlin; M L Shelanski; L A Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  The 14-3-3 proteins: gene, gene expression, and function.

Authors:  Yasuo Takahashi
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

3.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  Identification of Novel 14-3-3 Residues That Are Critical for Isoform-specific Interaction with GluN2C to Regulate N-Methyl-D-aspartate (NMDA) Receptor Trafficking.

Authors:  Connie Chung; Wei-Hua Wu; Bo-Shiun Chen
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

Review 5.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

6.  14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.

Authors:  S J Choi; S Y Park; T H Han
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

7.  14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.

Authors:  Jian Wang; Haiyan Lou; Courtney J Pedersen; Amanda D Smith; Ruth G Perez
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 8.  14-3-3 proteins in neuronal development and function.

Authors:  E M Skoulakis; R L Davis
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

9.  Molecular organization and tissue-specific expression of an Arabidopsis 14-3-3 gene.

Authors:  C J Daugherty; M F Rooney; P W Miller; R J Ferl
Journal:  Plant Cell       Date:  1996-08       Impact factor: 11.277

10.  Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

Authors:  Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.